Clinical significance of prognostic nutritional index (PNI) in malignant melanoma

被引:0
作者
Cem Mirili
Ali Yılmaz
Serkan Demirkan
Mehmet Bilici
Salim Basol Tekin
机构
[1] Ataturk University Faculty of Medicine,Department of Medical Oncology
[2] Katip Çelebi University Ataturk Education and Research Hospital,Department of Dermatology
来源
International Journal of Clinical Oncology | 2019年 / 24卷
关键词
Malignant melanoma; Prognostic nutritional index; Neutrophil–lymphocyte ratio; Systemic immune-inflammation index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1301 / 1310
页数:9
相关论文
共 134 条
[1]  
Friberg S(2015)Cancer metastases: early dissemination and late recurrences Cancer Growth Metastasis 8 43-49
[2]  
Nystrom A(2016)Metastatic melanoma treatment: combining old and new therapies Crit Rev Oncol Hematol 98 242-253
[3]  
Davey RJ(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[4]  
van der Westhuizen A(2016)Malignant melanoma: beyond the basics Plast Reconstr Surg 138 330-340
[5]  
Bowden NA(2018)Advanced melanoma: current treatment options, biomarkers, and future perspectives Am J Clin Dermatol 19 303-317
[6]  
Siegel RL(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-289
[7]  
Miller KD(2013)Melanoma epidemiology, biology and prognosis EJC Suppl 11 81-91
[8]  
Jemal A(2015)Inflammation fuels tumor progress and metastasis Curr Pharm Des 21 3032-3040
[9]  
Pavri SN(1987)Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system J Immunol 139 2406-2413
[10]  
Clune J(2001)TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients Arch Immunol Ther Exp 49 63-69